Enzalutamide in European and North American men participating in the AFFIRM trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enzalutamide in European and North American men participating in the AFFIRM trial
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 115, Issue 1, Pages 41-49
Publisher
Wiley
Online
2014-08-14
DOI
10.1111/bju.12898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.
- (2017) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer: ESMO Consensus Conference Guidelines 2012
- (2013) A. Horwich et al. ANNALS OF ONCOLOGY
- Castration-resistant Prostate Cancer: Where We Stand in 2013 and What Urologists Should Know
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Early Detection of Prostate Cancer: European Association of Urology Recommendation
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Early Detection of Prostate Cancer: AUA Guideline
- (2013) H. Ballentine Carter et al. JOURNAL OF UROLOGY
- Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer
- (2013) A. S. Merseburger et al. ONCOLOGIST
- Treatment patterns and characteristics of European patients with castration-resistant prostate cancer
- (2013) Cora N Sternberg et al. BMC Urology
- Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities
- (2012) Heather Payne et al. BJU INTERNATIONAL
- Drivers for change in the management of prostate cancer - Guidelines and new treatment techniques
- (2012) J.M. Wolff et al. BJU INTERNATIONAL
- Therapeutic Strategies for Bone Metastases and Their Clinical Sequelae in Prostate Cancer
- (2012) Karen A. Autio et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Les décisions sont-elles homogènes en réunion de concertation pluridisciplinaire (RCP) en onco-urologie ? Comparaison des choix thérapeutiques dans quatre RCP parisiennes
- (2012) F. Audenet et al. PROGRES EN UROLOGIE
- Pathophysiologie und Androgendeprivationstherapie des kastrationsresistenten Prostatakarzinoms
- (2012) A.S. Merseburger et al. UROLOGE
- Health-economic review of zoledronic acid for the management of skeletal-related events in bone-metastatic prostate cancer
- (2012) John A Carter et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Targeting Continued Androgen Receptor Signaling in Prostate Cancer
- (2011) C. Massard et al. CLINICAL CANCER RESEARCH
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2011) Nicolas Mottet et al. EUROPEAN UROLOGY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel options for the treatment of castration-resistant prostate cancer
- (2011) Carsten-H. Ohlmann et al. WORLD JOURNAL OF UROLOGY
- Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry
- (2010) Gerard P. McVey et al. BJU INTERNATIONAL
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer
- (2008) Andrea Gallina et al. BJU INTERNATIONAL
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search